Altered oxidative stress indexes related to disease progression marker in human immunodeficiency virus infected patients with Antiretroviral Therapy

Biomedicine and Aging Pathology

Volumn 1, Issue 1, 2011, Pages 8-15

  Gil, Lizette ^a   Tarinas, Alicia ^a   Hernández, Dayme ^a   Riverón, Beatriz Vega ^a   Pérez, Daniel ^b   Tápanes, Rolando ^a   Capo, Virginia ^a   Pérez, Jorge ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b Clinical Department   (Cuba)

Author keywords

Antiretroviral; HIV; Oxidative stress

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CATALASE; CD38 ANTIGEN; GLUTATHIONE; HYDROPEROXIDE; INDINAVIR; LAMIVUDINE; MALONALDEHYDE; NEVIRAPINE; STAVUDINE; SUPEROXIDE DISMUTASE; ZIDOVUDINE;

ADULT; BODY MASS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DNA FRAGMENTATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROGNOSIS; PROTEIN DEGRADATION; REDOX STRESS; REVIEW; VIRUS LOAD;

EID: 79960454157     PISSN: 22105220     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomag.2010.09.001     Document Type: Review

References (49)

1. UNAIDS. AIDS epidemic update 2008. Available at: http://www.unaids.org.
2. Centres for disease control and prevention. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR 58 (No. RR-4) AIDSinfo Web Site, available at: http://www.aidsinfo.nih.gov/ Guidelines; 2009.
3. Lewis W, Copeland WC, Day B. Mitochondrial DNA depletion, oxidative stress and mutation: mechanism of nucleoside reverse transcriptase inhibitor toxicity. Lab Invest 2001;81:777-90. (Pubitemid 32553400)
4. López S, Miró Ò, Beato A, et al. Assessment of mitochondrial toxicity of diverse highly active antiretroviral therapy regimens by a simultaneous genetic and biochemical approach. Antiviral Ther 2002;7:L15.
5. Gil L, Pérez D, Tápanes R, Pérez D, Pérez J, Grune T. Does mitochondrial dysfunction during antiretroviral therapy in human immunodeficiency virus infection suggest antioxidant supplementation as a beneficial option? Redox Report 2005;10:113-9. (Pubitemid 44111140)
6. Lee H, Hanes J, Johnson KA. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 2003;42:14711-9. (Pubitemid 37553499)
7. Israel N, Gougerot-Pocidalo MA. Oxidative stress in human immunodeficiency virus infection. CMLS 1997;53:864-70. (Pubitemid 28021500)
8. Romero-Avila D, Roche E. The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. Med Hyp 1998;51:169-73. (Pubitemid 28381116)
9. Sonnerborg A, Carlin G, Akerlund B, Jarstrand C. Increased production of malondialdehyde in patients with HIV infection. Scand J Infect Dis 1988;20:287-90.
10. Favier A, Sappey C, Leclerc P, Faure P, Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 1994;91:165-80. (Pubitemid 24168463)
11. Allard J, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998;67:143-7. (Pubitemid 28037639)
12. Gil L, Martínez G, González I, Tarinas A, Alvarez A, Giuliani A, et al. Contribution to characterization of oxidative stress in HIV/AIDS patients. Pharmacol Res 2003;47:217-24. (Pubitemid 36259924)
13. Pasupthi P, Ramachandran T, Sindhu PJ, Saravanan G, Bakthavathsalam G. Enhanced oxidative stress markers and antioxidant imbalance in HIV infection and aids patients. J Sci Res 2009;1:370-80.
14. González I, Gil L, Molina R, González A, Toledo ME, Díaz-Jidy M, et al. Características inmunológicas de los niños infectados por vía vertical con el VIH: estudio de casos y controles. Rev Inv Clin 2005;57:498-504. (Pubitemid 41644838)
15. Jaworowsi A, Crowe SM. Does HIV cause depletion of CD4+ T cells in vivo by the induction of apoptosis? Immunol Cell Biol 1999;77:90-8. (Pubitemid 29111595)
16. Kruman I, Nath A, Mattson M. HIV-1 protein Tat induces apoptosis inhipocampal neurons by a mechanism involving caspase activation, calcium overload and oxidative stress. Exp Neurob 1998;154:276-88. (Pubitemid 29044201)
17. Mollace V, Salvemini D, Riley DP. The contribution of oxidative stress in apoptosis of human cultured astroglial cells induced by supernatants of HIV-1-infected macrophages. J Leukoc Biol 2002;71:65-72. (Pubitemid 34062773)
18. Sloand EM, Young NS, Kumar P, Weichold FF, Sato T, Maciejewski JP. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood 1997;89:1357-63. (Pubitemid 27080000)
19. Cullen BR. Regulation of human immunodeficiency virus replication. Annu Rev Microbiol 1991;45:219-50. (Pubitemid 21903790)
20. Day BJ, Lewis W. Oxidative stress in NRTI-induced toxicity. Cardiovasc Toxicol 2004;4:207-16.
21. Zwart LL, Meerman JHN, Commandeur JNM, Vermeulen NPE. Biomarkers of free radical damage. Applications in experimental animals and in humans. Free Radic Biol Med 1999;26:202-26. (Pubitemid 29001507)
22. Froebel KS, Raab GM, D'Alessandro C, Armitage MP, MacKenzie KM, Struthers M, et al. A single measurement of CD38/CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable. Clin Exp Immunol 2000;122:72-8.
23. Desrosiers RC. Strategies used by human immunodeficiency virus that allow persistent viral replication. Nat Med 1999;5:723-5. (Pubitemid 29318597)
24. Shepard B, Loutfy MR, Raboud J, Mandy F, Kovacs CM, Diong C, et al. Early changes in T-Cell activation predict antiretroviral success in salvage therapy of HIV infection. Acquir Immune Defic Syndr 2008;48:149-55.
25. Sahnoun Z, Jamoussi K, Zeghal KM. Free radicals and antioxidants: human physiology, pathology and therapeutics aspects. Therapie 1997;52:251-70.
26. Giorgi JV. Characterization of Tlymphocytes subset alterations by flow cytometry in HIV disease. Ann N Y Acad Sci 1993;677:126-37. (Pubitemid 23161915)
27. Sedlak J, Lindsay RH. Estimation of total protein bound and nonprotein sulfhydryl group in tissue with Ellmanǐs reagent. Anal Biochem 1968;25:192-205.
28. Ozdemirler G, Mehmetcik G, Oztezcan S, Toker G, Sivas A, Uysal M. Peroxidation potential and antioxidant activity of serum in patients with diabetes mellitus and myocardial infarction. Metab Res 1995;271:194-6.
29. Burton K. Determination of DNA concentration with diphenylamine. Methods Enzymol 1968;12B:163-7.
30. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. Weinheim: Verlag Chemie; 1974. pp. 673-8.
31. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguye-Knoa, Nguyen AT, Zingraff J, et al. Advanced oxidation protein product as novel mediators of inflammation and monocytes activation in chronic renal failure. J Immunol 1998;161:2524-32. (Pubitemid 28397070)
32. Peterhans E. Reactive oxygen species and nitric oxidein viral diseases. Bio Trace Elem Res 1997;56:107-16. (Pubitemid 27198253)
33. Gil L, Ferreira R. Antioxidants, micronutrients and human immune deficiency virus. Antioxidants and quality of life. http://www.antioxidantes. com.ar/12/FrArt242.htm; 2004.
34. Stehbens WE. Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol 2004;77:121-32. (Pubitemid 39209294)
35. Alessio M, Roggero S, Funaro A, De Monte LBPL, Geuna M, Malavasi F. CD38 molecule: structural and biochemical analysis on human Tlymphocytes, thymocytes and plasma cells. J Immunol 1998;145:878-84.
36. Benito JM, López M, Lozano S, Martinez P, González-Lahoz J, Soriano V. CD38 expression on CD8 Tlymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy. AIDS Res Hum Retroviruses 2004;20:227-33. (Pubitemid 38280934)
37. Ngondi JL, Oben J, Forkah DM, Etame LH, Mbanya D. The effect of different combination therapies on oxidative stress markers in HIV infected patients in Cameroon. AIDS Res Ther 2006;3:19.
38. Hulgan T, Morrow J, D'Aquila RT, Raffanti S, Morgan M, Rebeiro P, et al. Oxidant stress is increased during treatment of human immunodeficiency virus infection. Clin Infect Dis 2003;37:1711-7. (Pubitemid 37549961)
39. Hulgan T, Hughes M, Sun X, Smeaton L, Terry E, Robbins G, et al. Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study. J Acquir Immune Defic Syndr 2006;42:1-5.
40. Redhage LA, Shintani A, Haas DW, Emeagwali N, Markovic M, Oboho I, et al. Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults. HIV Clin Trials 2009;10:181-92.
41. Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, et al. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients. Clin Therap 2007;29:448-55.
42. Aukrust P, Muller F, Svardal A, Ueland T, Berge RK, Froland SS. Disturbed glutathione metabolism and decreased antioxidants levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy-potential immunomodulatory effects of antioxidants. J Infect Dis 2003;188:232-8. (Pubitemid 36898155)
43. Feng JY, Johnson AA, Johnson KA, Anderson KS. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. J Biol Chem 2001;276:23832-7.
44. Coté HC, Yip B, Asselin JJ, Chan JW, Hogg RS, Harrigan R, et al. Mitochondrial: nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens. J Infect Dis 2003;187:1972-6. (Pubitemid 36724498)
45. Prakash O, Teng S, Ali M, Zhu X, Coleman R, Dabdoub RA, et al. The HIV-1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice. Arch Biochem Biophys 1997;343:173-80. (Pubitemid 27297578)
46. Lim SE, Copeland WC. Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J Biol Chem 2001;276:23616-23.
47. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signalling, and cell injury. Free Radic Biol Med 2000;28:1456-62. (Pubitemid 30604227)
48. McComsey GA, Paulsen DM, Lonergan JT, Hessenthaler SM, Hoppel CL, Williams VC, et al. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir and zidovudine. AIDS 2005;10:15-23. (Pubitemid 40111014)
49. Gil L, Lewis L, Martinez G, Tarinas, González I, Alvarez A, et al. Effect of increased of dietary micronutrient intake on oxidative stress indicators in HIV/AIDS patients. Int J Vit Nut Res 2005;75:19-27. (Pubitemid 40387171)